In his article in the Art at JAMA Cole presents the work of Théo
van Rysselberghe who was born in Ghent and studied at the city’s Royal Academy
of Fine Arts. Van Rysselberghe was a
frequent visitor to Spain and North Africa, and the Mediterranean region at
large. In the course of his career as an artist, he was influenced by Paul
Signac, Georges Seurat, and Henri de Toulouse-Lautrec among others. In his painting of the Garden of the
Generalife in Granada, he demonstrates how visual perception changes when
an observer moves from the shade into bright sunlight. The color and symmetry of the garden draw one’s
attention, but on a hot summer day, lingering in the shade is so enjoyable as
all people who live in hot climates know.
The estates and gardens at Generalife were built in the 14th
century and it was a favorite retreat of the Emirs of the Alhambra who stayed there when
they in need of quiet time to reflect on state and personal issues. Its arcades enclosed
formal gardens with fountains and reflecting pools, and the songs of birds such
as nightingales were heard in its shady alcoves.
According to legend, a prince was
raised in the comfort and seclusion of the Generalife to prevent him from
falling in love until he reached a suitable age. One day he rescued a dove from a hawk, and in
return the dove told him of a princess in a secret garden surrounded by high
walls. Soon the prince was off to find her, the implication being that a life
of ease and beauty is no substitute for love.
JAMA. 2015;314(1):10-11
Courtesy of the
Fine Arts Museums of San Francisco (https://www.famsf.org/), San
Francisco, California; gift of B. Gerald Cantor, 1969
|
Sunday, December 13, 2015
Garden of the Generalife in Granada
Tuesday, December 1, 2015
No need to print mammograms on films; FDA
An FDA communiqué to mammography facilities “said that printing breast
images to hard-copy film is no longer necessary and can be performed at the
discretion of individual centers”.
Over the past 20 years,
there has been significant evolution in mammography, with the shift from
screen-film to digital imaging being the most prominent change.
A total of 39 million
procedures were performed in the 8,737 mammographic facilities that were
accredited by the FDA as of Nov 1, 2015.
Today fewer than 350 screen-film units remain in use in the U.S. The
nearly universal availability of computers for viewing of digital images
diminishes the need for a facility to maintain a printer.
Today, with many
mammograms shared on computer media such as compact discs or via online access,
the provision of printed hard copies is becoming obsolete.
Saturday, November 14, 2015
Computer-Aided Detection did not improve Digital Screening Mammography's Diagnostic Accuracy
Lehman
et al in a paper published by JAMAInternal Medicine report on their findings that suggest that computer-assisted
detection (CAD) used in most mammograms added no benefit to breast cancer
screening while it substantially increased costs.
The
authors compared the accuracy of digital screening mammography
interpreted with (n = 495 818) versus without (n = 129 807) CAD from 2003 through 2009 in 323 973 women. 271 radiologists in 66 facilities interpreted
the mammographic studies. They found
3159 breast cancers within 1 year of the screening.
Screening performance was not
improved with CAD on any metric assessed. Mammography sensitivity was 85.3%
with and 87.3% without CAD. Specificity was 91.6% with and 91.4% without CAD.
There was no difference in cancer detection rate (4.1 in 1000 women screened
with and without CAD). Computer-aided detection did not improve intra-radiologist
performance. Sensitivity was significantly lower for mammograms interpreted
with versus without CAD in the subset of radiologists who interpreted both with
and without CAD.
The authors concluded CAD does not
improve diagnostic accuracy of mammography. These results suggest that while
insurers pay an additional $400 million a year for CAD, its addition to
standard mammography had no beneficial impact to women.
Sunday, November 1, 2015
American Cancer Society Updated Guidelines for Breast Cancer Screening
Breast cancer is a leading cause of
premature mortality among US women. Oeffinger at al report in
JAMA the American Cancer Society
(ACS) 2015 update regarding the frequency of screening mammography in women at
average risk.
The ACS recommends that women with
an average risk of breast cancer should undergo annual screening mammography
starting at age 45 years (strong recommendation).
Women 55 years and older should
transition to biennial screening (strong
recommendation).
Women should continue screening
mammography as long as their overall health is good and they have a life
expectancy of 10 years or longer (qualified recommendation).
Women should have the opportunity
to have annual screening between at the ages of 40-45 received a qualified
recommendation.
The ACS does not recommend clinical
breast examination for breast cancer screening among average-risk women at any
age (qualified recommendation).
These updated ACS guidelines
provide evidence-based recommendations for breast cancer screening for women at
average risk of breast cancer.
Monday, October 12, 2015
Complications of Central Venous Catheterization by Insertion Site
Parienti et al report in NEJM the finds of a trial regarding
complications from central venous catheters depending on the insertion
site.
In this multicenter trial, they
randomly assigned non-tunneled central venous catheterization in patients in
the intensive care unit to the subclavian, jugular, or femoral veins.
The primary outcome measure was catheter-related
bloodstream infection and symptomatic deep-vein thrombosis.
A total of 3471 catheters were
inserted in 3027 patients. In the three-choice comparison, there were 8, 20,
and 22 primary outcome events in the subclavian, jugular, and femoral groups,
respectively (1.5, 3.6, and 4.6 per 1000 catheter-days; P=0.02). In pairwise
comparisons, the risk of the primary outcome was significantly higher in the
femoral group than in the subclavian group and in the jugular group than in the
subclavian group, whereas the risk in the femoral group was similar to that in the
jugular group. In the three-choice comparison, pneumothorax requiring
chest-tube insertion occurred in 13 (1.5%) of the subclavian-vein insertions
and 4 (0.5%) of the jugular-vein insertions.
The authors concluded that subclavian
vein catheterization was associated with a lower risk of bloodstream infection
and symptomatic thrombosis and a higher risk of pneumothorax than jugular vein
or femoral vein catheterization.
N Engl J Med 2015; 373:1220-1229
Thursday, October 1, 2015
Carotid Occlusion May Not Be Associated With High Risk For Stroke
Yang et al published on JAMA Neurology their retrospective analysis of patients
who presented at two atherosclerosis
clinics in Ontario with asymptomatic carotid artery stenoses
that were followed for 20-years with carotid duplex scans.
Among the 3681 patients who had annual
carotid ultrasound examinations, 316 (8.6%) were asymptomatic before an
occlusion that occurred during observation period.
Of the new occlusions, 254 of 316
[80.4%] occurred before 2002, when medical therapy was less intensive; the
frequency decreased by quartile of years (P < .001, χ2 test). Only 1 patient (0.3%) had a stroke at the time
of the occlusion, and only 3 patients (0.9%) had an ipsilateral stroke during
follow-up (all before 2005).
In Kaplan-Meier survival analyses,
neither severity of stenosis nor contralateral occlusion predicted the risk of
ipsilateral stroke or transient ischemic attack, death from stroke, or death from
unknown cause at a mean follow-up of 2.56 years. In Cox proportional hazards regression analyses, only age
(P = .02), sex (P = .01), and carotid plaque burden (P = .006) significantly predicted risk of those events.
The authors concluded that the risk
of progression to carotid occlusion is well below the risk of carotid stenting
or endarterectomy and has decreased markedly with more intensive medical
therapy. Preventing carotid occlusion is not a valid indication for intervention to prevent
occlusion as the circle of Willis offers substantial protection.
JAMA Neurol. 2015.1843
Subscribe to:
Posts (Atom)